InsidersTradesSigma
Track the Chimeric Therapeutics Limited share price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are listed on the AU market, under the oversight of ASX. Operating in the Health Care sector, Chimeric Therapeutics Limited has published 1 insider filings. Market capitalisation: €2.5m. The latest transaction was disclosed on 5 May 2026 (Change in Substantial Holding). Among the most active insiders: GKCC LLC. Every trade is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 May 2026
About Chimeric Therapeutics Limited
Chimeric Therapeutics Limited is a biopharmaceutical company focused on developing innovative cell therapies for cancer treatment. It is listed on the Australian Securities Exchange (ASX).